AI assistant
Tevogen Bio Holdings Inc. — Director's Dealing 2024
Dec 26, 2024
33780_dirs_2024-12-26_277d8c9b-1143-4c95-9b2b-bf0200df0bb9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tevogen Bio Holdings Inc. (TVGN)
CIK: 0001860871
Period of Report: 2024-12-23
Reporting Person: Sordillo Victor J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-23 | Common Stock | A | 240000 | $0.00 | Acquired | 336962 | Direct |
| 2024-12-23 | Common Stock | A | 240000 | $0.00 | Acquired | 576962 | Direct |
Footnotes
F1: Represents a grant of restricted stock units ("RSUs") under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan.
F2: The RSUs, which were granted in recognition of the reporting person's past service on the Issuer's Board of Directors, vested in full immediately upon grant.
F3: The RSUs will vest ratably in four equal annual installments beginning on January 1, 2025 provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock.